Macoin J, Lissilaa R, Sancheti P, Reddy V, Back J, Wolff G. Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses. J of Skin [Internet]. 2018Dec.17 [cited 2024Sep.20];2:S62. Available from: https://dermsquared.com/skin/article/view/458